Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India flag India · Delayed Price · Currency is INR
694.10
+19.95 (2.96%)
At close: Aug 21, 2026

NSE:NEPHROPLUS Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
768.4670.96351.33-117.89-219.75
Depreciation & Amortization
886.49719.18540.19465.16389.03
Other Amortization
8.365.518.663.633.69
Loss (Gain) From Sale of Assets
12.76-0.65--
Asset Writedown & Restructuring Costs
12.714.2612.28-27.68
Loss (Gain) From Sale of Investments
-91.35-7.55---
Loss (Gain) on Equity Investments
30.93----
Stock-Based Compensation
95.1463.818.6420.875.4
Provision & Write-off of Bad Debts
237.7888.57114.8966.6883.28
Other Operating Activities
420.98250.476.18207.48-5.45
Change in Accounts Receivable
-687.94-667.31-505.6-543.04-234.48
Change in Inventory
-54.930.679.7-108.3816.99
Change in Accounts Payable
328.07398.71183.68135.4511.48
Change in Other Net Operating Assets
358.39-173.8-17.8-17.2741.31
Operating Cash Flow
2,3261,353722.8112.69119.18
Operating Cash Flow Growth
71.84%87.25%541.41%-5.45%-63.39%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-1,189-997.75-773.49-715.69-429.7
Sale of Property, Plant & Equipment
2.22----
Cash Acquisitions
-503.99-125.41-281.37-64.17-626.82
Sale (Purchase) of Intangibles
-4.26-10.22-26.52-21.69-3.51
Investment in Securities
-1,49647.27459.66-46.03-642.23
Other Investing Activities
-913.27-164.62115.1265.5227.38
Investing Cash Flow
-4,104-1,251-506.6-782.06-1,675

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-81.0513.73620.78-
Long-Term Debt Issued
--723.68388.61184.03
Total Debt Issued
-81.05737.411,009184.03
Short-Term Debt Repaid
-878.86----189.9
Long-Term Debt Repaid
-1,267-328.91-310.52-238.81-224.65
Total Debt Repaid
-2,146-328.91-310.52-238.81-414.55
Net Debt Issued (Repaid)
-2,146-247.86426.89770.58-230.53
Issuance of Common Stock
3,902979.655.5823.631,811
Other Financing Activities
-184.78-188.08-165.08-194.55-111.98
Financing Cash Flow
1,571543.71267.39599.661,474

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
188.190.21-12.6824.8-
Net Cash Flow
-19.28646.66470.91-44.91-81.95

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
1,136355.72-50.69-603-310.52
Free Cash Flow Growth
219.47%----
Free Cash Flow Margin
11.38%4.71%-0.90%-13.79%-9.80%
Free Cash Flow Per Share
11.984.25-0.63-7.83-37.45
Levered Free Cash Flow
913.5110.9920.41-1,417-279.76
Unlevered Free Cash Flow
1,276228.91139.16-1,326-219.18

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
184.78188.1165.08161.1396.66
Cash Income Tax Paid
274.779.5780.63-46.2147.94
Change in Working Capital
-56.41-441.73-330.02-533.24-164.7